# Merck KGaA - Inspection Records

Source: https://www.keypedia.com/companies/merck-kgaa/b5abb295-f221-4b66-9a49-d564f70c388b

> Inspection records and compliance data for Merck KGaA in Darmstadt, None. Access full analysis and detailed observations.

---

## Details

- Name: Merck KGaA
- FEI Number: 3002806906
- City: Darmstadt
- State: None
- Country Name: Germany
- Address Line 1: Frankfurter Str. 250
- Zip Code: None
- Business Operations: API MANUFACTURE, FDF MANUFACTURE, REPACK

## Related Documents

- [FDA Inspection 1233993 - Merck KGaA - 2024-07-19](https://www.keypedia.com/records/fda_inspections/merck-kgaa/b4911050-d784-40ae-8305-98f4c06a9345) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2024
- [FDA Inspection 1241023 - Merck KGaA - 2023-10-06](https://www.keypedia.com/records/fda_inspections/merck-kgaa/5f02914e-4266-43fe-9c7d-5814a3ee6c40) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 6, 2023
- [FDA Inspection 1029948 - Merck KGaA - 2017-09-08](https://www.keypedia.com/records/fda_inspections/merck-kgaa/1ebb03c7-356a-4abf-9604-5b880656b035) — classification: No Action Indicated (NAI), source: FDA, date: September 8, 2017
- [FDA Inspection 1029948 - Merck KGaA - 2017-09-08](https://www.keypedia.com/records/fda_inspections/merck-kgaa/6cc0f417-d04a-4832-8815-a53be8e4fb75) — classification: No Action Indicated (NAI), source: FDA, date: September 8, 2017
- [FDA Inspection 867759 - Merck KGaA - 2014-02-27](https://www.keypedia.com/records/fda_inspections/merck-kgaa/358cb71a-98e1-4dec-8a9e-be82221ff4a0) — classification: No Action Indicated (NAI), source: FDA, date: February 27, 2014
- [FDA Inspection 653955 - Merck KGaA - 2010-02-10](https://www.keypedia.com/records/fda_inspections/merck-kgaa/33bc8741-9271-4f87-92b1-75ad36c18cd1) — classification: No Action Indicated (NAI), source: FDA, date: February 10, 2010
- [483 - Merck KGaA - 2009-07-02](https://www.keypedia.com/records/483/merck-kgaa/58f91917-eff3-4b66-9c3b-de4e723183eb) — source: FDA, date: July 2, 2009
- [FDA Inspection 599121 - Merck KGaA - 2009-07-02](https://www.keypedia.com/records/fda_inspections/merck-kgaa/c5f114c3-c9d9-4b0e-85ca-a9c600a6078e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 2, 2009

## Related Companies

- [Pharmaron Manufacturing Services (US) LLC](https://www.keypedia.com/companies/pharmaron-manufacturing-services-us-llc/ae7512a8-bd98-4a34-a61e-4c3bc455ed65)
- [Piramal Pharma Limited](https://www.keypedia.com/companies/piramal-pharma-limited/426a2612-5a5c-4bc9-9073-420430b16072)
- [Glaxo Operations UK Limited](https://www.keypedia.com/companies/glaxo-operations-uk-limited/203ed5e0-7ae4-490f-b37a-9293e17eae84)
- [Galephar Pharmaceutical Research Inc.](https://www.keypedia.com/companies/galephar-pharmaceutical-research-inc/e38305f7-c401-4d03-8aa7-1f520179a4ea)
- [Bakelite Chemicals LLC](https://www.keypedia.com/companies/bakelite-chemicals-llc/77828887-3e5a-4cff-bcca-3423659055d3)
- [Hamari PFST, Ltd.](https://www.keypedia.com/companies/hamari-pfst-ltd/17548bf6-b8d5-4469-be75-78ca6f0f7bd5)
- [Second Pharma Co., Ltd.](https://www.keypedia.com/companies/second-pharma-co-ltd/8edb6004-77bb-46b8-9347-b7df0bdb670f)
- [Sanofi-Aventis Deutschland GmbH](https://www.keypedia.com/companies/sanofi-aventis-deutschland-gmbh/07c96432-bb43-45e5-a80d-e4bca284dbab)
- [Taro Pharmaceutical Industries, Ltd.](https://www.keypedia.com/companies/taro-pharmaceutical-industries-ltd/75bff305-a575-43eb-9c35-401fed5479be)
- [Duke Medical Center-Carolinas Cord Blood Bank and Stem Cell Laboratory](https://www.keypedia.com/companies/duke-medical-center-carolinas-cord-blood-bank-and-stem-cell-laboratory/c0d3517e-a147-4272-aa62-323feeca0e0b)

## Related Officers

- [investigator](https://www.keypedia.com/people/evelyn-taha/52095559-e6cc-447e-9f96-b235f52f741a)